New drug cocktail tested for leukemia that Won't quit
NCT ID NCT05029141
Summary
This study is testing whether a combination of three drugs—chidamide, azacitidine, and the HAG regimen—can help control acute myeloid leukemia (AML) in adults when the cancer has come back or hasn't responded to previous treatments. The main goal is to see how well this combination works to reduce or eliminate cancer cells and what side effects it causes. It is for adults aged 18-70 whose leukemia is considered relapsed or refractory.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affliated Hospital of Soochow University
Suzhou, Jiangsu, 215006, China
Conditions
Explore the condition pages connected to this study.